On-chip complement activation adds an extra dimension to antigen microarrays

Molecular and Cellular Proteomics

Volumn 6, Issue 1, 2007, Pages 133-140

  Papp, Krisztián ^a   Szekeres, Zsuzsanna ^a   Terényi, Nóra ^a   Isaák, Andrea ^a   Erdei, Anna ^a   Prechl, József ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY LABELING; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; COVALENT BOND; DNA BINDING; FLUORESCENCE ANALYSIS; FOREIGN BODY REACTION; IMMUNOASSAY; INNATE IMMUNITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN INTERACTION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; COMPLEMENT ACTIVATION; COMPLEMENT C3; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN ARRAY ANALYSIS;

MUS;

EID: 33846545129     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.T600036-MCP200     Document Type: Article

References (45)

1. Morgan B. P., Marchbank, K. J., Longhi, M. P., Harris, C. L., and Gallimore, A. M. (2005) Complement: central to innate immunity and bridging to adaptive responses. ImmunoL Lett. 97, 171-179
2. Medzhitov, R., and Janeway, C. A., Jr. (1999) Innate immune induction of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol. 64, 429-435
3. Thirumalapura, N. R., Morton, R. J., Ramachandran, A., and Malayer, J. R. (2005) Lipopolysaccharide microarrays for the detection of antibodies. J. Immunol. Methods 298, 73-81
4. Mezzasoma, L., Bacarese-Hamilton, T., Di Cristina, M., Rossi, R., Bistoni, F., and Crisanti, A. (2002) Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48, 121-130
5. Thirumalapura, N. R., Ramachandran, A., Morton, R. J., and Malayer, J. R. (2006) Bacterial cell microarrays for the detection and characterization of antibodies against surface antigens. J. Immunol. Methods 309, 48-54
6. Hiller, R., Laffer, S., Harwanegg, C., Huber, M., Schmidt, W. M., Twardosz, A., Barletta, B., Becker, W. M., Blaser, K., Breiteneder, H., Chapman, M., Crameri, R., Duchene, M., Ferreira, F., Fiebig, H., Hoffmann-Sommergruber, K., King, T. P., Kleber-Janke, T., Kurup, V. P., Lehrer, S. B., Lidholm, J., Muller, U., Pini, C., Reese, G., Scheiner, O., Scheynius, A., Shen, H. D., Spitzauer, S., Suck, R., Swoboda, I., Thomas, W., Tinghino, R., Van Hage-Hamsten, M., Virtanen, T., Kraft, D., Muller, M. W., and Valenta, R. (2002) Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 16, 414-416
7. Wiltshire, S., O'Malley, S., Lambert, J., Kukanskis, K., Edgar, D., Kingsmore, S. F., and Schweitzer, B. (2000) Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin. Chem. 46, 1990-1993
8. Bacarese-Hamilton, T., Mezzasoma, L., Ingham, C., Ardizzoni, A., Rossi, R., Bistoni, F., and Crisanti, A. (2002) Detection of allergen-specific IgE on microarrays by use of signal amplification techniques. Clin. Chem. 48, 1367-1370
9. Graham, K. L., Robinson, W. H., Steinman, L., and Utz, P. J. (2004) High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases. Autoimmunity 37, 269-272
10. Horn, S., Lueking, A., Murphy, D., Staudt, A., Gutjahr, C., Schulte, K., Konig, A., Landsberger, M., Lehrach, H., Felix, S. B., and Cahill, D. J. (2006) Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics 6, 605-613
11. Luelking, A., Huber, O., Wirths, C., Schulte, K., Stieler, K. M., Blume-Peytavi, U., Kowald, A., Hensel-Wiegel, K., Tauber, R., Lehrach, H., Meyer, H. E., and Cahill, D. J. (2005) Profiling of alopecia areata autoantigens based on protein microarray technology. Mol. Cell. Proteomics 4, 1382-1390
12. Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Bruce, B., Fries, J. F., Sonderstrup, G., Monach, P., Drijfhout, J. W., van Venrooij, W. J., Utz, P. J., Genovese, M. C., and Robinson, W. H. (2005) Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52, 2645-2655
13. Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., de Vegvar, H. E., Skriner, K., Hirschberg, D. L., Morris, R. I., Muller, S., Pruijn, G. J., van Venrooij, W. J., Smolen, J. S., Brown, P. O., Steinman, L., and Utz, P. J. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295-301
14. Porter, R. R., and Reid, K. B. (1979) Activation of the complement system by antibody-antigen complexes: the classical pathway. Adv. Protein Chem. 33, 1-71
15. Gewurz, H., Zhang, X. H., and Lint, T. F. (1995) Structure and function of the pentraxins. Curr. Opin. Immunol. 7, 54-64
16. Kojima, M., Presanis, J. S., and Sim, R. B. (2003) The mannose-binding lectin (MBL) route for activation of complement. Adv. Exp. Med. Biol. 535, 229-250
17. Matsushita, M., Endo, Y., Hamasaki, N., and Fujita, T. (2001) Activation of the lectin complement pathway by ficolins. Int. Immunopharmacol. 1, 359-363
18. Petersen, S. V., Thiel, S., and Jensenius, J. C. (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38, 133-149
19. Thurman, J. M., and Holers, V. M. (2006) The central role of the alternative complement pathway in human disease. J. Immunol. 176, 1305-1310
20. Janssen, B. J., Huizinga, E. G., Raaijmakers, H. C., Roos, A., Daha, M. R., Nilsson-Ekdahl, K., Nilsson, B., and Gros, P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511
21. Pangbum, M. K., and Muller-Eberhard, H. J. (1980) Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. J Exp. Med. 152, 1102-1114
22. Circolo, A., Garnier, G., Fukuda, W., Wang, X., Hidvegi, T., Szalai, A. J., Briles, D. E., Volanakis, J. E., Wetsel, R. A., and Gotten, H. R. (1999) Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42, 135-149
23. Bellinger-Kawahara, C., and Horwitz, M. A. (1990) Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of Legionella pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J. Exp. Med. 172, 1201-1210
24. Matsumoto, M., Yamashita, F., Iida, K., Tomita, M., and Seya, T. (1995) Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3. J. Exp. Med. 181, 115-125
25. Thornton, B. P., Vetvicka, V., and Ross, G. D. (1994) Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152, 1727-1737
26. Bobrow, M. N., Harris, T. D., Shaughnessy, K. J., and Litt, G. J. (1989) Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125 279-285
27. Lucisano Valim, Y. M., and Lachmann, P. J. (1991) The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin. Exp. Immunol. 84, 1-8
28. Stewart, W. W., Johnson, A., Steward, M. W., Whaley, K., and Kerr, M. A. (1990) The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation. Mol. Immunol. 27, 423-428
29. Garred, P., Michaelsen, T. E., and Aase, A. (1989) The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration. Scand. J. Immunol. 30, 379-382
30. Arnold, J. N., Dwek, R. A., Rudd, P. M., and Sim, R. B. (2006) Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol. Lett. 106, 103-110
31. Aasa-Chapman, M. M., Holuigue, S., Aubin, K., Wong, M., Jones, N. A., Cornforth, D., Pellegrino, P., Newton, P., Williams, I., Borrow, P., and McKnight, A. (2005) Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection. J. Virol. 79, 2823-2830
32. Azeredo da Silveira, S., Kikuchi, S., Fossati-Jimack, L., Moll, T., Saito, T., Verbeek, J. S., Botto, M., Walport, M. J., Carroll, M., and Izui, S. (2002) Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J. Exp. Med. 195, 665-672
33. Salmon, J. E., Girardi, G., and Holers, V. M. (2002) Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann. Rheum. Dis. 61, Suppl. 2, ii46-ii50
34. Werwitzke, S., Trick, D., Kamino, K., Matthias, T., Kniesch, K., Schlegelberger, B., Schmidt, R. E., and Witte, T. (2005) Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum. 52, 3629-3638
35. Isenberg, D. (2004) Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus? Lupus 13, 881-885
36. Forger, F., Matthias, T., Oppermann, M., Becker, H., and Helmke, K. (2004) Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13, 36-44
37. Nossent, J. C., Huysen, V., Smeenk, R. J., and Swaak, A. J. (1989) Low avidity antibodies to dsDNA as a diagnostic tool. Ann. Rheum. Dis. 48, 748-752
38. Mackworth-Young, C. G., Chan, J. K., Bunn, C. C., Hughes, G. R., and Gharavi, A. E. (1986) Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity. Ann. Rheum. Dis. 45, 314-318
39. Lueking, A., Possling, A., Huber, O., Beveridge, A., Horn, M., Eickhoff, H., Schuchardt, J., Lehrach, H., and Cahill, D. J. (2003) A nonredundant human protein chip for antibody screening and serum profiling. Mol. Cell. Proteomics 2, 1342-1349
40. Robinson, W. H., Fontoura, P., Lee, B. J., de Vegvar, H. E., Tom, J., Pedotti, R., DiGennaro, C. D., Mitchell, D. J., Fong, D., Ho, P. P., Ruiz, P. J., Maverakis, E., Stevens, D. B., Bernard, C. C., Martin, R., Kuchroo, V. K., van Noort, J. M., Genain, C. P., Amor, S., Olsson, T., Utz, P. J., Garren, H., and Steinman, L. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21, 1033-1039
41. Girardi, G., Redecha, P., and Salmon, J. E. (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10, 1222-1226
42. Ostergaard, J., Hansen, T. K., Thiel, S., and Flyvbjerg, A. (2005) Complement activation and diabetic vascular complications. Clin. Chim. Acta 361, 10-19
43. Kostner, K. M. (2004) Activation of the complement system: a crucial link between inflammation and atherosclerosis? Eur. J. Clin. Investig. 34, 800-802
44. Arumugam, T. V., Shiels, I. A., Woodruff, T. M., Granger, D. N., and Taylor, S. M. (2004) The role of the complement system in ischemia-reperfusion injury. Shock 21, 401-409
45. McGeer, P. L., and McGeer, E. G. (2002) The possible role of complement activation in Alzheimer disease. Trends Mol. Med. 8, 519-523